[{"id":"24050ecc-e087-49d7-8b3c-491960aa21ef","acronym":"","url":"https://clinicaltrials.gov/study/NCT00200174","created_at":"2021-01-18T00:40:51.455Z","updated_at":"2024-07-02T16:35:43.977Z","phase":"","brief_title":"Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in Postmenopausal Women With a History of Breast Cancer Who Have No Clinical Evidence of Disease","source_id_and_acronym":"NCT00200174","lead_sponsor":"Memorial Sloan Kettering Cancer Center","biomarkers":" PGR","pipe":"","alterations":" ","tags":["PGR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e exemestane • raloxifene hydrochloride"],"overall_status":"Completed","enrollment":" Enrollment 11","initiation":"Initiation: 07/01/1999","start_date":" 07/01/1999","primary_txt":" Primary completion: 07/01/2003","primary_completion_date":" 07/01/2003","study_txt":" Completion: 08/01/2008","study_completion_date":" 08/01/2008","last_update_posted":"2023-07-04"},{"id":"0f7140e0-a533-48b6-8970-9fc5964136de","acronym":"","url":"https://clinicaltrials.gov/study/NCT00723398","created_at":"2021-01-18T02:43:22.782Z","updated_at":"2024-07-02T16:37:05.662Z","phase":"","brief_title":"Nutritional Supplements and Hormonal Manipulations for Breast Cancer Prevention","source_id_and_acronym":"NCT00723398","lead_sponsor":"Milton S. Hershey Medical Center","biomarkers":" IL6 • IGF1 • IGFBP3 • CRP","pipe":"","alterations":" ","tags":["IL6 • IGF1 • IGFBP3 • CRP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e pitavastatin • raloxifene hydrochloride"],"overall_status":"Completed","enrollment":" Enrollment 266","initiation":"Initiation: 03/01/2009","start_date":" 03/01/2009","primary_txt":" Primary completion: 04/01/2015","primary_completion_date":" 04/01/2015","study_txt":" Completion: 04/01/2015","study_completion_date":" 04/01/2015","last_update_posted":"2018-11-01"}]